MASS Price / Book | 908 DEVICES INC.

908 Devices Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

908 Devices Inc. price/book ratio for the quarter ending 2026-06-30 was 2.61, a 50.64% increase year-over-year.
908 Devices Inc. price/book ratio for the quarter ending 2026-03-31 was 1.71, a 70.20% increase year-over-year.
908 Devices Inc. price/book ratio for the quarter ending 2025-12-31 was 1.32, a 96.56% increase year-over-year.
908 Devices Inc. price/book ratio for the quarter ending 2025-09-30 was 2.32, a 152.83% increase year-over-year.
908 Devices Inc. price/book ratio for fiscal 2026 was 2.61.
908 Devices Inc. price/book ratio for fiscal 2025 was 1.32, a 96.56% increase from fiscal 2024.
908 Devices Inc. price/book ratio for fiscal 2024 was 0.67, a 69.44% decline from fiscal 2023.
908 Devices Inc. price/book ratio for fiscal 2023 was 2.2, a 73.09% increase from fiscal 2022.

Available history: 2020-12-31 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	2.61	$330.35M	$126.77M
2026-03-31	1.71	$229.35M	$134.17M
2025-12-31	1.32	$190.33M	$143.7M
2025-09-30	2.32	$316.76M	$136.3M
2025-06-30	1.73	$257.45M	$148.82M
2025-03-31	1	$160.11M	$159.42M
2024-12-31	0.67	$77.22M	$114.59M
2024-09-30	0.92	$120.45M	$131.04M
2024-06-30	1.14	$178.35M	$156.36M
2024-03-31	1.58	$248.58M	$156.89M
2023-12-31	2.2	$364.86M	$165.49M
2023-09-30	1.27	$215.59M	$169.93M
2023-06-30	1.27	$221.76M	$174.46M
2023-03-31	1.53	$275.73M	$180.61M
2022-12-31	1.27	$242.77M	$190.6M
2022-09-30	2.65	$520.68M	$196.5M
2022-06-30	3.23	$649.23M	$201.12M
2022-03-31	2.88	$595.66M	$206.8M
2021-12-31	3.75	$803.96M	$214.6M
2021-09-30	7.38	$906.17M	$122.78M
2021-06-30	8.43	$1.07B	$126.67M
2021-03-31	9.92	$1.32B	$133.31M
2020-12-31	11.17	$1.55B	$139.04M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	2.61	$330.35M	$126.77M
2025-12-31	1.32	$190.33M	$143.7M
2024-12-31	0.67	$77.22M	$114.59M
2023-12-31	2.2	$364.86M	$165.49M
2022-12-31	1.27	$242.77M	$190.6M
2021-12-31	3.75	$803.96M	$214.6M
2020-12-31	11.17	$1.55B	$139.04M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)	United States	$0.491B	-3.95
EyePoint, Inc. (EYPT)	United States	$0.314B	-3.96
Cytek Biosciences, Inc. (CTKB)	United States	$0.744B	-7.15
Quanterix Corp (QTRX)	United States	$0.150B	-1.65
Nautilus Biotechnology, Inc. (NAUT)	United States	$0.129B	-4.16
Seer, Inc. (SEER)	United States	$0.104B	-1.34
Precipio, Inc. (PRPO)	United States	$0.043B	-36.70
HARVARD BIOSCIENCE INC (HBIO)	United States	$0.037B	-2.70
Bionano Genomics, Inc. (BNGO)	United States	$0.020B	-0.42
ASTROTECH Corp (ASTC)	United States	$0.013B